Ding J - Search Results

1

Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells.

He CX, Ai J, Xing WQ, Chen Y, Zhang HT, Huang M, Hu YH, Ding J, Geng MY. He CX, et al. Among authors: ding j. Acta Pharmacol Sin. 2014 Jan;35(1):89-97. doi: 10.1038/aps.2013.125. Epub 2013 Nov 18. Acta Pharmacol Sin. 2014. PMID: 24241352 Free PMC article.

2

[Protein phosphatase 2A: its structure, function and activity regulation].

Liu WJ, Shen Y, Ding J. Liu WJ, et al. Among authors: ding j. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Feb;35(2):105-12. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003. PMID: 12545214 Review. Chinese.

3

Actinomycin D inhibiting K562 cell apoptosis elicited by salvicine but not decreasing its cytotoxicity.

Qing C, Miao ZH, Tong LJ, Zhang JS, Ding J. Qing C, et al. Among authors: ding j. Acta Pharmacol Sin. 2003 May;24(5):415-21. Acta Pharmacol Sin. 2003. PMID: 12740176 Free article.

4

Studies of marine sulfated polymannuroguluronate on endothelial cell proliferation and endothelial immunity and related mechanisms.

Wang L, Geng M, Li J, Guan H, Ding J. Wang L, et al. Among authors: ding j. J Pharmacol Sci. 2003 Aug;92(4):367-73. doi: 10.1254/jphs.92.367. J Pharmacol Sci. 2003. PMID: 12939521 Free article.

5

Anticancer activity of methoxymorpholinyl doxorubicin (PNU 152243) on human hepatocellular carcinoma.

Yuan S, Zhang X, Lu L, Xu C, Yang W, Ding J. Yuan S, et al. Among authors: ding j. Anticancer Drugs. 2004 Jul;15(6):641-6. doi: 10.1097/01.cad.0000132238.23050.f5. Anticancer Drugs. 2004. PMID: 15205610

6

Acidic oligosaccharide sugar chain, a marine-derived acidic oligosaccharide, inhibits the cytotoxicity and aggregation of amyloid beta protein.

Hu J, Geng M, Li J, Xin X, Wang J, Tang M, Zhang J, Zhang X, Ding J. Hu J, et al. Among authors: ding j. J Pharmacol Sci. 2004 Jun;95(2):248-55. doi: 10.1254/jphs.fpj04004x. J Pharmacol Sci. 2004. PMID: 15215650 Free article.

7

Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome (AIDS) drug candidate, targeting CD4 in lymphocytes.

Miao B, Geng M, Li J, Li F, Chen H, Guan H, Ding J. Miao B, et al. Among authors: ding j. Biochem Pharmacol. 2004 Aug 15;68(4):641-9. doi: 10.1016/j.bcp.2004.04.009. Biochem Pharmacol. 2004. PMID: 15276071

8

Evaluation of active recombinant catalytic domain of human ErbB-2 tyrosine kinase, and suppression of activity by a naturally derived inhibitor, ZH-4B.

Guo XN, Zhong L, Zhang XH, Zhao WM, Zhang XW, Lin LP, Ding J. Guo XN, et al. Among authors: ding j. Biochim Biophys Acta. 2004 Aug 4;1673(3):186-93. doi: 10.1016/j.bbagen.2004.04.015. Biochim Biophys Acta. 2004. PMID: 15279890

9

[Heat shock protein 90: novel target for cancer therapy].

Chen Y, Ding J. Chen Y, et al. Among authors: ding j. Ai Zheng. 2004 Aug;23(8):968-74. Ai Zheng. 2004. PMID: 15301726 Review. Chinese.

10

Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect.

Tan WF, Zhang XW, Li MH, Yue JM, Chen Y, Lin LP, Ding J. Tan WF, et al. Among authors: ding j. Eur J Pharmacol. 2004 Sep 24;499(3):219-28. doi: 10.1016/j.ejphar.2004.07.063. Eur J Pharmacol. 2004. PMID: 15381043

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,320 results

Search Page

Filters